NOVOCURE LTD (NVCR) Stock Earnings & Estimates
NASDAQ:NVCR - JE00BYSS4X48 - Common Stock
12.33 USD
+0.3 (+2.54%)
12.23 USD
-0.1 (-0.81%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 537.8M 0.52% | 509.338M -5.29% | 605.22M 18.82% | 645.64M 6.68% | 690.88M 7.01% | 796.12M 15.23% | 954.56M 19.90% | 1.461B 53.05% | 1.769B 21.08% | N/A | |
| EBITDA YoY % growth | -78.88M -131.66% | -221.901M -181.31% | -157.258M 29.13% | -58.06M 63.08% | -40.573M 30.12% | 16.733M 141.24% | -57.884M -445.93% | 590.17M 1,119.57% | 1.188B 101.30% | N/A | |
| EBIT YoY % growth | -89.5M -102.03% | -232.87M -160.19% | -168.493M 27.65% | -176.768M -4.91% | -177.276M -0.29% | -149.832M 15.48% | -78.138M 47.85% | 139.84M 278.96% | 337.93M 141.65% | 474.3M 40.35% | |
| Operating Margin | -16.64% | -45.72% | -27.84% | -27.38% | -25.66% | -18.82% | -8.19% | 9.57% | 19.10% | N/A | |
| EPS YoY % growth | -0.88 -57.14% | -1.95 -121.59% | -1.56 20.00% | -1.61 -3.34% | -1.74 -7.87% | -1.36 21.69% | -0.85 37.27% | 0.82 195.52% | 3.13 283.75% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 -53.94% | -0.50 17.78% | -0.45 -43.87% | -0.44 -21.76% | -0.43 0.55% | -0.42 16.31% | -0.33 26.82% | -0.30 32.52% | -0.31 28.61% | -0.29 31.96% |
| Revenue Q2Q % growth | 161.82M 4.34% | 163.28M 1.25% | 166.39M 7.35% | 169.04M 6.45% | 169.84M 4.96% | 173.93M 6.52% | 174.3M 4.75% | 178.84M 5.80% | 186.17M 9.61% | 191.34M 10.01% |
| EBITDA Q2Q % growth | -7.864M 67.18% | 2.13M 104.09% | -5.221M 83.80% | -6.258M 80.10% | -2M 74.57% | 31.932M 1,399.15% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -45.728M -42.49% | -52.111M 17.68% | -40.152M -12.90% | -39.292M -2.80% | -42.043M 8.06% | -40.183M 22.89% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.36 -16.13% | -0.39 | 0.03 | 8.12% |
| Q1 2025 Q2Q % growth | -0.31 13.89% | -0.47 | 0.16 | 34.54% |
| Q4 2024 Q2Q % growth | -0.61 -35.56% | -0.35 | -0.26 | -73.92% |
| Q3 2024 Q2Q % growth | -0.28 39.13% | -0.34 | 0.06 | 17.78% |
| Q2 2024 Q2Q % growth | -0.31 42.59% | -0.42 | 0.11 | 26.08% |
| Q1 2024 Q2Q % growth | -0.36 28.00% | -0.43 | 0.07 | 16.51% |
| Q4 2023 Q2Q % growth | -0.45 -25.00% | -0.53 | 0.08 | 15.39% |
| Q3 2023 Q2Q % growth | -0.46 -84.00% | -0.54 | 0.08 | 14.10% |
| Q2 2023 Q2Q % growth | -0.54 -134.78% | -0.51 | -0.03 | -5.80% |
| Q1 2023 Q2Q % growth | -0.50 -1,150.00% | -0.33 | -0.17 | -51.47% |
| Q4 2022 Q2Q % growth | -0.36 -44.00% | -0.31 | -0.05 | -15.72% |
| Q3 2022 Q2Q % growth | -0.25 -92.31% | -0.27 | 0.02 | 6.25% |
| Q2 2022 Q2Q % growth | -0.23 -64.29% | -0.15 | -0.08 | -55.51% |
| Q1 2022 Q2Q % growth | -0.04 | -0.18 | 0.14 | 78.21% |
| Q4 2021 Q2Q % growth | -0.25 -725.00% | -0.10 | -0.15 | -141.64% |
| Q3 2021 Q2Q % growth | -0.13 -244.44% | -0.08 | -0.05 | -72.81% |
| Q2 2021 Q2Q % growth | -0.14 -800.00% | 0.01 | -0.15 | -1,643.92% |
| Q1 2021 Q2Q % growth | -0.04 -200.00% | 0.02 | -0.06 | -296.08% |
| Q4 2020 Q2Q % growth | 0.04 | 0.13 | -0.09 | -68.49% |
| Q3 2020 Q2Q % growth | 0.09 350.00% | 0.03 | 0.06 | 164.73% |
| Q2 2020 Q2Q % growth | 0.02 300.00% | 0.00 | 0.02 | 622.88% |
| Q1 2020 Q2Q % growth | 0.04 130.77% | 0.02 | 0.02 | 82.99% |
| Q4 2019 Q2Q % growth | 0.04 | 0.02 | 0.02 | 149.62% |
| Q3 2019 Q2Q % growth | 0.02 | -0.05 | 0.07 | 142.01% |
| Q2 2019 Q2Q % growth | -0.01 | -0.07 | 0.06 | 86.54% |
| Q1 2019 Q2Q % growth | -0.13 | -0.15 | 0.02 | 11.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 158.805M 5.62% | 157.29M | 1.515M | 0.96% |
| Q1 2025 Q2Q % growth | 154.994M 11.91% | 149.54M | 5.454M | 3.65% |
| Q4 2024 Q2Q % growth | 161.266M 20.54% | 160.97M | 296K | 0.18% |
| Q3 2024 Q2Q % growth | 155.095M 21.81% | 146.83M | 8.265M | 5.63% |
| Q2 2024 Q2Q % growth | 150.356M 19.28% | 138.54M | 11.816M | 8.53% |
| Q1 2024 Q2Q % growth | 138.503M 13.36% | 134.08M | 4.423M | 3.30% |
| Q4 2023 Q2Q % growth | 133.784M 4.19% | 133.81M | -26K | -0.02% |
| Q3 2023 Q2Q % growth | 127.321M -2.81% | 131.34M | -4.019M | -3.06% |
| Q2 2023 Q2Q % growth | 126.051M -10.54% | 126.74M | -689K | -0.54% |
| Q1 2023 Q2Q % growth | 122.182M -11.14% | 129.82M | -7.638M | -5.88% |
| Q4 2022 Q2Q % growth | 128.4M -3.60% | 130.82M | -2.42M | -1.85% |
| Q3 2022 Q2Q % growth | 131M -1.95% | 132.68M | -1.68M | -1.27% |
| Q2 2022 Q2Q % growth | 140.9M 5.54% | 137.69M | 3.21M | 2.33% |
| Q1 2022 Q2Q % growth | 137.5M 2.08% | 136.76M | 740K | 0.54% |
| Q4 2021 Q2Q % growth | 133.2M -7.50% | 139.81M | -6.61M | -4.73% |
| Q3 2021 Q2Q % growth | 133.6M 0.68% | 144.05M | -10.45M | -7.25% |
| Q2 2021 Q2Q % growth | 133.5M 15.19% | 144.73M | -11.23M | -7.76% |
| Q1 2021 Q2Q % growth | 134.7M 32.32% | 142.15M | -7.45M | -5.24% |
| Q4 2020 Q2Q % growth | 144M 45.16% | 144.12M | -120K | -0.08% |
| Q3 2020 Q2Q % growth | 132.7M 44.08% | 122.42M | 10.28M | 8.40% |
| Q2 2020 Q2Q % growth | 115.9M 33.68% | 108.15M | 7.75M | 7.17% |
| Q1 2020 Q2Q % growth | 101.8M 38.88% | 104.19M | -2.39M | -2.29% |
| Q4 2019 Q2Q % growth | 99.2M | 99.871M | -671K | -0.67% |
| Q3 2019 Q2Q % growth | 92.1M | 88.822M | 3.278M | 3.69% |
| Q2 2019 Q2Q % growth | 86.7M | 81.841M | 4.859M | 5.94% |
| Q1 2019 Q2Q % growth | 73.3M | 74.309M | -1.009M | -1.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.63% | 3.64% | 4.13% |
| Revenue | 0% | 0.22% | 0.5% | 1.06% |